Pharmaceutical Research

, Volume 31, Issue 11, pp 2940–2951 | Cite as

Modulating Protein Release Profiles by Incorporating Hyaluronic Acid into PLGA Microparticles Via a Spray Dryer Equipped with a 3-Fluid Nozzle

  • Feng Wan
  • Morten Jonas Maltesen
  • Sune Klint Andersen
  • Simon Bjerregaard
  • Stefania G. Baldursdottir
  • Camilla Foged
  • Jukka Rantanen
  • Mingshi Yang
Research Paper

ABSTRACT

Purpose

The purpose of this study was to modulate the release profiles of the model protein drug from spray dried poly(DL-lactic-co-glycolic acid) (PLGA) microparticles by incorporating hyaluronic acid (HA) in the formulation.

Methods

Bovine serum albumin (BSA)-loaded PLGA microparticles with or without HA were prepared using a spray dryer equipped with a 3-fluid nozzle. The effects of HA on the surface tension and the rheological behavior of the inner feed solution were investigated. The physicochemical properties of the resulting microparticles were characterized using scanning electron microscopy (SEM), laser diffraction (LD), confocal laser scanning microscopy (CLSM) and X-ray photoelectron spectroscopy (XPS). Circular dischoism (CD) was used to characterize conformational integrity of BSA released from the microparticles.

Results

Spherical microparticles with D50 of 5–10 μm were obtained. Addition of HA in inner feed solutions increased the feed viscosity, but with no influence on the surface tension. All inner feed solutions showed non-Newtonian shear thinning behavior and the rheological properties were not time dependent. The CLSM and XPS analyses suggested a core-shell like structure of the microparticles when HA was incorporated. The release profiles of BSA were extended and the initial burst releases were suppressed with an increase in HA in the microparticle formulations. In addition, HA seemed to protect BSA from degradation upon the spray-drying process.

Conclusions

The present work demonstrates the potential of HA to modulate protein release profile from PLGA microparticle formulations produced via spray drying using 3-fluid nozzle.

KEY WORDS

controlled release hyaluronic acid microencapsulation PLGA microparticles protein spray drying 

REFERENCES

  1. 1.
    Desai KG, Schwendeman SP. Active self-healing encapsulation of vaccine antigens in PLGA microspheres. J Control Release. 2013;165(1):62–74.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Giteau A, Venierjulienne M, Marchal S, Courthaudon J, Sergent M, Monteromenei C, et al. Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur J Pharm Biopharm. 2008;70(1):127–36.PubMedCrossRefGoogle Scholar
  3. 3.
    Mok H, Park TG. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent. Eur J Pharm Biopharm. 2008;70(1):137–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Shi Y, Li LC. Current advances in sustained-release systems for parenteral drug delivery. Expert Opin Drug Deliv. 2005;2(6):1039–58.PubMedCrossRefGoogle Scholar
  5. 5.
    Brown LR. Commercial challenges of protein drug delivery. Expert Opin Drug Deliv. 2005;2(1):29–42.PubMedCrossRefGoogle Scholar
  6. 6.
    Wu F, Jin T. Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances. AAPS PharmSciTech. 2008;9(4):1218–29.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Wan F, Maltesen MJ, Andersen SK, Bjerregaard S, Foged C, Rantanen J, et al. One-step production of protein loaded PLGA microparticles via spray drying using 3-fluid nozzle. Pharma Res. 2014;Accept.Google Scholar
  8. 8.
    Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res. 2008;25(5):999–1022.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Wan F, Bohr A, Maltesen MJ, Bjerregaard S, Foged C, Rantanen J, et al. Critical solvent properties affecting the particle formation process and characteristics of celecoxib-loaded PLGA microparticles via spray-drying. Pharm Res. 2013;30(4):1065–76.PubMedCrossRefGoogle Scholar
  10. 10.
    Wang J, Wang BM, Schwendeman SP. Characterization of the initial burst release of a model peptide from poly(D, L-lactide-co-glycolide) microspheres. J Control Release. 2002;82(2–3):289–307.PubMedCrossRefGoogle Scholar
  11. 11.
    Ganesh S, Iyer AK, Morrissey DV, Amiji MM. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors. Biomaterials. 2013;34(13):3489–502.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Oh EJ, Park K, Kim KS, Kim J, Yang JA, Kong JH, et al. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release. 2010;141(1):2–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Gomez-Gaete C, Fattal E, Silva L, Besnard M, Tsapis N. Dexamethasone acetate encapsulation into Trojan particles. J Control Release. 2008;128(1):41–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Brown MB, Jones SA. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venereol. 2005;19(3):308–18.PubMedCrossRefGoogle Scholar
  15. 15.
    Liao YH, Jones SA, Forbes B, Martin GP, Brown MB. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv. 2005;12(6):327–42.PubMedCrossRefGoogle Scholar
  16. 16.
    Yoon HY, Kim HR, Saravanakumar G, Heo R, Chae SY, Um W, et al. Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting. J Control Release. 2013;172:653–61.PubMedCrossRefGoogle Scholar
  17. 17.
    Borzacchiello A, Mayol L, Ramires PA, Pastorello A, Di Bartolo C, Ambrosio L, et al. Structural and rheological characterization of hyaluronic acid-based scaffolds for adipose tissue engineering. Biomaterials. 2007;28(30):4399–408.PubMedCrossRefGoogle Scholar
  18. 18.
    Baumann MD, Kang CE, Stanwick JC, Wang Y, Kim H, Lapitsky Y, et al. An injectable drug delivery platform for sustained combination therapy. J Control Release. 2009;138(3):205–13.PubMedCrossRefGoogle Scholar
  19. 19.
    Iskandar F, Nandiyanto AB, Widiyastuti W, Young LS, Okuyama K, Gradon L. Production of morphology-controllable porous hyaluronic acid particles using a spray-drying method. Acta Biomater. 2009;5(4):1027–34.PubMedCrossRefGoogle Scholar
  20. 20.
    Gomez Gaete C, Tsapis N, Silva L, Bourgaux C, Fattal E. Morphology, structure and supramolecular organization of hybrid 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine-hyaluronic acid microparticles prepared by spray drying. Eur J Pharm Sci. 2008;34(1):12–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Gomez-Gaete C, Tsapis N, Silva L, Bourgaux C, Besnard M, Bochot A, et al. Supramolecular organization and release properties of phospholipid-hyaluronan microparticles encapsulating dexamethasone. Eur J Pharm Biopharm. 2008;70(1):116–26.PubMedCrossRefGoogle Scholar
  22. 22.
    Surendrakumar K, Martyn GP, Hodgers EC, Jansen M, Blair JA. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J Control Release. 2003;91(3):385–94.PubMedCrossRefGoogle Scholar
  23. 23.
    Lee ES, Kwon MJ, Na K, Bae JH. Protein release behavior from porous microparticle with lysozyme/hyaluronate ionic complex. Colloids Surf B: Biointerfaces. 2007;55(1):125–30.PubMedCrossRefGoogle Scholar
  24. 24.
    Suttiprasit P, Krisdhasima V, McGuire J. The surface activity of α-lactalbumin, β-lactoglobulin, and bovine serum albumin: I. Surface tension measurements with single-component and mixed solutions. J Colloid Interface Sci. 1992;154(2):316–26.CrossRefGoogle Scholar
  25. 25.
    McClellan SJ, Franses EI. Effect of concentration and denaturation on adsorption and surface tension of bovine serum albumin. Colloids Surf B. 2003;28(1):63–75.CrossRefGoogle Scholar
  26. 26.
    Adler M, Unger M, Lee G. Surface composition of spray-dried particles of bovine serum albumin/trehalose/surfactant. Pharm Res. 2000;17(7):863–70.PubMedCrossRefGoogle Scholar
  27. 27.
    Sharma V, Jaishankar A, Wang Y-C, McKinley GH. Rheology of globular proteins: apparent yield stress, high shear rate viscosity and interfacial viscoelasticity of bovine serum albumin solutions. Soft Matter. 2011;7(11):5150.CrossRefGoogle Scholar
  28. 28.
    Serno T, Hartl E, Besheer A, Miller R, Winter G. The role of polysorbate 80 and HPbetaCD at the air-water interface of IgG solutions. Pharm Res. 2013;30(1):117–30.PubMedCrossRefGoogle Scholar
  29. 29.
    Kim J-H, Taluja A, Knutson K, Han Bae Y. Stability of bovine serum albumin complexed with PEG-poly(l-histidine) diblock copolymer in PLGA microspheres. J Control Release. 2005;109(1–3):86–100.PubMedCrossRefGoogle Scholar
  30. 30.
    Geidobler R, Konrad I, Winter G. Can controlled ice nucleation improve freeze-drying of highly-concentrated protein formulations? J Pharm Sci. 2013;102(11):3915–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Siepmann J, Siepmann F. Modeling of diffusion controlled drug delivery. J Control Release. 2012;161(2):351–62.PubMedCrossRefGoogle Scholar
  32. 32.
    Misljenovic N, Schuller RB, Rukke E-O, Bringas CS. Rheological characterization of liquid raw materials for solid biofuel production. Annu Trans Nord Rheol Soc. 2013;21:61–8.Google Scholar
  33. 33.
    Mei F, Chen DR. Investigation of compound jet electrospray: particle encapsulation. Phys Fluids. 2007;19(10):103303.CrossRefGoogle Scholar
  34. 34.
    Elias HG. An introduction to polymer science. 1ed –Weinheim; New York; Basel; Cambridge; Tokyo: VCH 1997.Google Scholar
  35. 35.
    Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—a review. Int J Pharm. 2011;415(1–2):34–52.PubMedCrossRefGoogle Scholar
  36. 36.
    Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm. 2008;350(1–2):14–26.PubMedCrossRefGoogle Scholar
  37. 37.
    Jiang G, Qiu W, DeLuca PP. Preparation and in vitroin vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Pharm Res. 2003;20(3):452–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Lee ES, Park KH, Park IS, Na K. Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-co-glycolide) microparticle. Int J Pharm. 2007;338(1–2):310–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Lee ES, Kwon MJ, Lee H, Kim JJ. Stabilization of protein encapsulated in poly(lactide-co-glycolide) microspheres by novel viscous S/W/O/W method. Int J Pharm. 2007;331(1):27–37.PubMedCrossRefGoogle Scholar
  40. 40.
    Wan F, Wu JX, Bohr A, Baldursdottir SG, Maltesen MJ, Bjerregaard S, et al. Impact of PLGA molecular behavior in the feed solution on the drug release kinetics of spray dried microparticles. Polymer. 2013;54(21):5920–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Feng Wan
    • 1
  • Morten Jonas Maltesen
    • 2
  • Sune Klint Andersen
    • 3
  • Simon Bjerregaard
    • 3
  • Stefania G. Baldursdottir
    • 1
  • Camilla Foged
    • 1
  • Jukka Rantanen
    • 1
  • Mingshi Yang
    • 1
  1. 1.Department of Pharmacy, Faculty of Health and Medical SciencesUniversity of CopenhagenCopenhagen ØDenmark
  2. 2.Biopharma Application Development, Novozymes A/SBagsvaerdDenmark
  3. 3.Preformulation and Delivery/Oral Protein Delivery, Diabetes Research Unit, Novo Nordisk A/SMåløvDenmark

Personalised recommendations